Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $71.00.

USPH has been the subject of a number of research reports. Zacks Investment Research cut shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Saturday, August 26th. Barrington Research downgraded shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, November 3rd. Cantor Fitzgerald reiterated a “buy” rating and set a $72.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, September 26th. Sidoti upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $62.00 to $74.00 in a report on Friday, September 8th. Finally, BidaskClub upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, October 25th.

In related news, CEO Christopher J. Reading sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $66.52, for a total value of $997,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $72.56, for a total transaction of $145,120.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,250 shares of company stock valued at $1,986,645. Insiders own 3.10% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the stock. Pinebridge Investments L.P. grew its holdings in U.S. Physical Therapy by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock valued at $100,000 after purchasing an additional 17 shares during the period. Texas Permanent School Fund grew its holdings in U.S. Physical Therapy by 0.8% in the second quarter. Texas Permanent School Fund now owns 9,142 shares of the company’s stock valued at $552,000 after purchasing an additional 76 shares during the period. Municipal Employees Retirement System of Michigan grew its holdings in U.S. Physical Therapy by 3.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock valued at $178,000 after purchasing an additional 90 shares during the period. Los Angeles Capital Management & Equity Research Inc. grew its holdings in U.S. Physical Therapy by 3.0% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 6,868 shares of the company’s stock valued at $415,000 after purchasing an additional 200 shares during the period. Finally, Thrivent Financial For Lutherans grew its holdings in U.S. Physical Therapy by 5.9% in the second quarter. Thrivent Financial For Lutherans now owns 7,570 shares of the company’s stock valued at $457,000 after purchasing an additional 420 shares during the period. Hedge funds and other institutional investors own 94.12% of the company’s stock.

U.S. Physical Therapy (NYSE USPH) opened at $70.85 on Thursday. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.30. The stock has a market cap of $902.70, a PE ratio of 34.66, a price-to-earnings-growth ratio of 3.08 and a beta of 1.08. U.S. Physical Therapy has a 52-week low of $56.50 and a 52-week high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). The business had revenue of $103.03 million for the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. equities analysts expect that U.S. Physical Therapy will post 2.07 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, December 8th. Stockholders of record on Friday, November 17th were issued a dividend of $0.20 per share. The ex-dividend date was Thursday, November 16th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.13%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 48.19%.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/u-s-physical-therapy-inc-usph-given-consensus-recommendation-of-hold-by-brokerages/1775295.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.